ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

OLMA Olema Pharmaceuticals Inc

12,36
-0,10 (-0,80%)
15 Jun 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Olema Pharmaceuticals Inc OLMA NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,10 -0,80% 12,36 06:00:09
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
12,37 12,14 12,78 12,36 12,46
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
14.6.202422:39EDGAR2Form 8-K - Current report
07.6.202400:49EDGAR2Form SC 13D/A - General statement of acquisition of..
06.6.202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.6.202416:05EDGAR2Form 144 - Report of proposed sale of securities
06.6.202416:02EDGAR2Form 144 - Report of proposed sale of securities
05.6.202403:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.6.202422:28GLOBEOlema Oncology Reports Inducement Grants Under Nasdaq..
04.6.202421:09EDGAR2Form 144 - Report of proposed sale of securities
03.6.202420:55EDGAR2Form 144 - Report of proposed sale of securities
31.5.202418:17EDGAR2Form 144 - Report of proposed sale of securities
28.5.202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.5.202413:03GLOBEOlema Oncology to Participate in Upcoming Investor..
15.5.202413:06EDGAR2Form 8-K - Current report
15.5.202413:01GLOBEOlema Oncology Announces Promising New Data for Palazestrant..
08.5.202422:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08.5.202422:06EDGAR2Form 8-K - Current report
08.5.202422:02GLOBEOlema Oncology Reports First Quarter 2024 Financial Results..
08.5.202413:02GLOBEOlema Oncology Announces New Clinical Data for Palazestrant..
07.5.202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.5.202422:00EDGAR2Form 144 - Report of proposed sale of securities
02.5.202422:37GLOBEOlema Oncology Reports Inducement Grants Under Nasdaq..
01.5.202413:02GLOBEOlema Oncology to Participate in Upcoming Investor..
08.4.202422:30GLOBEOlema Oncology to Participate in Canaccord Genuity 2024..
02.4.202422:29GLOBEOlema Oncology Reports Inducement Grants Under Nasdaq..
11.3.202421:31EDGAR2Form S-8 - Securities to be offered to employees in employee..
11.3.202421:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
11.3.202421:05EDGAR2Form 8-K - Current report
11.3.202421:03GLOBEOlema Oncology Reports Fourth Quarter and Full-Year 2023..
06.3.202413:03GLOBEOlema Oncology Announces Publication of Data Highlighting..
04.3.202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.3.202422:30GLOBEOlema Oncology Reports Inducement Grants Under Nasdaq..
29.2.202420:26EDGAR2Form 144 - Report of proposed sale of securities
14.2.202422:08EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14.2.202418:53EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12.2.202423:16EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
12.2.202406:15EDGAR2Form EFFECT - Notice of Effectiveness
06.2.202413:01GLOBEOlema Oncology to Participate in Upcoming Investor..
05.2.202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.2.202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.2.202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.2.202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.2.202422:30GLOBEOlema Oncology Reports Inducement Grants Under Nasdaq..
01.2.202421:24EDGAR2Form 144 - Report of proposed sale of securities
31.1.202422:21EDGAR2Form S-3 - Registration statement under Securities Act of..
31.1.202420:58EDGAR2Form 144 - Report of proposed sale of securities
29.1.202413:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.1.202415:07EDGAR2Form 8-K - Current report
08.1.202414:18EDGAR2Form 8-K - Current report
08.1.202414:12GLOBEOlema Oncology Nominates OP-3136, an Orally Bioavailable..
05.1.202423:26EDGAR2Form 8-K - Current report

Kürzlich von Ihnen besucht

Delayed Upgrade Clock